Results 11 to 20 of about 1,514 (136)

Generalized bullous fixed drug eruption induced by chlordiazepoxide: a case report of a potentially lethal adverse effect [PDF]

Consortium Psychiatricum
BACKGROUND: Fixed drug eruption is a type of adverse drug reaction affecting the skin, marked by recurrent rashes that appear at the same site each time a particular drug is taken.
Rishabh Singh, Vaibhav Kumar Sudhanshu, Mariam Shafiq, Markanday Sharma   +3 more
doaj   +3 more sources

Tadalafil-Induced Generalized Bullous Fixed Drug Eruption: A Rare Side Effect of a Common Drug. [PDF]

Cureus, 2023
Tadalafil is a phosphodiesterase-5 (PDE-5) inhibitor, an FDA-approved treatment for erectile dysfunction (ED), pulmonary arterial hypertension (PAH), benign prostate hyperplasia, etc.
Sarawgi D, Rudra O.
europepmc   +4 more sources

Two cases of generalized bullous fixed-drug eruption triggered by etodolac

Turkderm Turkish Archives of Dermatology and Venereology, 2023
[No abstract available]
Işıl Göğem İmren, Şule Gökşin, Merve Akbay, Sevilay Ertürk, Neşe Çallı Demirkan, Şeniz Duygulu   +5 more
doaj   +6 more sources

Nimesulide-Associated Generalized Bullous Fixed Drug Eruption: A Rare Pharmacovigilance Case Report. [PDF]

Cureus
Generalized Bullous Fixed Drug Eruption (GBFDE) is a severe variant of Fixed Drug Eruption (FDE) characterized by widespread dusky erythematous plaques and blistering, often mimicking Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).
Marshal M, Aggarwal S, Joseph G, Bhatti N, Badyal DK.   +4 more
europepmc   +5 more sources

Generalized Bullous Fixed Drug Eruption to Fluconazole with Positive Patch Testing and Confirmed Tolerance to Itraconazole

Iranian Journal of Allergy, Asthma and Immunology, 2021
Generalized bullous fixed drug eruption (GBFDE) is a specific variant of fixed drug eruption that belongs to severe cutaneous adverse reactions (SCARs) and its diagnosis is based mainly on clinical course and especially on the reoccurrence of typical ...
Michael Makris, Christos Fokoloros, Anna Syrmali, Zoi Tsakiraki, Vasileia Damaskou, Evangelia Papadavid   +5 more
doaj   +5 more sources

Doxycycline induced generalized bullous fixed drug eruption

Indian Journal of Dermatology, 2016
Indrashis Podder, Somodyuti Chandra, Anupam Das, Ramesh Chandra Gharami   +3 more
doaj   +4 more sources

Generalized bullous drug eruption triggered by ceftriaxone: a case report and literature overview [PDF]

Dermatology Reports
Ceftriaxone is a widely used third-generation cephalosporin antibiotic known for its efficacy and safety. However, hypersensitivity reactions, including rare cases of generalized bullous fixed drug eruption (GBFDE), have been reported.
Khuzama Alfalah, Khalid Nabil Nagshabandi, Hala Abdullah Almusa   +2 more
doaj   +3 more sources

Generalized Bullous Fixed Drug Eruption Associated with Allopurinol: A Case Report

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)
Background: Generalized Bullous Fixed Drug Eruption (GBFDE) is an uncommon type of FDE and is defined as typical FDE lesions accompanied by widespread bullous and skin erosions that is often confused with SJS-TEN due to their similarity in clinical ...
Anselma Dyah Kartika Hadi, Cagar Irwin Taufan Pamungkas, Asri Ayu Firdausi, Agnellia Maulidya Utami   +3 more
doaj   +3 more sources

Generalized bullous fixed drug eruption to fluconazole; with cross-reactivity to tinidazole [PDF]

Indian Journal of Dermatology, 2019
Hershada S Mithari, Prachi V Gole, Vidya D Kharkar, Sunanda A Mahajan   +3 more
doaj   +4 more sources

Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19). [PDF]

J Eur Acad Dermatol Venereol, 2022
is a major tool in the efforts towards ending the coronavirus disease 2019 (COVID-19) pandemic. Cutaneous reactions associated with the COVID-19 vaccination have been reported.
Ben Salem C, Khelif A, Sahnoun D, Ghariani N, Sriha B, Denguezli M.   +5 more
europepmc   +2 more sources